8-KEarnings & ResultsRegulation FD

CENTENE CORP 8-K Report, Financial Results (Jan 7, 2019)

Filed January 7, 2019For Securities:CNC

Summary

Centene Corporation (CNC) filed an 8-K on January 7, 2019, primarily to announce its participation in the J.P. Morgan Annual Healthcare Conference. During this presentation, the company confirmed its previously issued guidance for both 2018 and 2019, which had been initially disclosed on December 13, 2018. Investors should note that no new financial information or material updates beyond the confirmation of existing guidance were provided in this filing. The company explicitly stated that the guidance information, while presented, is not being "filed" under Section 18 of the Securities Exchange Act of 1934, and is not incorporated by reference into other SEC filings unless specifically stated. This means the information is for informational purposes related to the conference presentation and does not carry the same legal implications as formally filed financial data. Investors seeking detailed financial performance data should refer to the company's previous announcements and filings.

Key Highlights

  • 1Centene Corporation (CNC) participated in the J.P. Morgan Annual Healthcare Conference on January 7, 2019.
  • 2The company confirmed its previously announced 2018 and 2019 guidance ranges during the conference presentation.
  • 3The guidance being discussed was initially issued on December 13, 2018.
  • 4No new financial results or significant updates beyond the confirmation of existing guidance were disclosed in this 8-K.
  • 5The information provided is considered Regulation FD disclosure and is not "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934.
  • 6The filing serves as a confirmation of prior guidance, directing investors to the company's investor relations website for details of the December 13, 2018 guidance.

Frequently Asked Questions

No, Centene Corporation did not release new financial results. This 8-K filing primarily served to confirm the company's previously issued guidance for 2018 and 2019 during its presentation at the J.P. Morgan Annual Healthcare Conference.

Confirming guidance suggests that the company is on track to meet its previously stated financial expectations. For investors, this provides a degree of confidence in the company's outlook, barring any new information that might have been disclosed verbally at the conference itself (which is not detailed in this 8-K).

The 8-K filing states that the guidance was previously announced on December 13, 2018, and a copy can be found on the Company's investor relations website. Investors should refer to that specific guidance document for detailed information.

No, the filing explicitly states that the information contained in this Form 8-K shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. This means it does not carry the same legal liability as formally filed financial information.